PRLS

(redirected from Primary Restless Legs Syndrome)
AcronymDefinition
PRLSPuerto Rican and Latino Studies (program of study)
PRLSPrepaid Rental Listing Service (California)
PRLSProjekta Reforme Lokalne Samouprave (Croatian: Local Government Reform Project)
PRLSPotential Rotary Leadership Seminar (Rotary Club)
PRLSPosterior Reversible Leukoencephalopathy Syndrome (medical disorder)
PRLSPrimary Restless Legs Syndrome
References in periodicals archive ?
We are pleased to provide a new treatment for moderate-to-severe primary Restless Legs Syndrome.
The capacity of Horizant in the treatment of patients with moderate-to-severe primary Restless Legs Syndrome was demonstrated in two 12-week clinical trials in adults.
The efficacy of Horizant in the treatment of patients with moderate-to-severe primary Restless Legs Syndrome was demonstrated in two 12-week clinical trials in adults.
This is the first medication in its class to be approved for the treatment of moderate-to-severe primary Restless Legs Syndrome.
7 April 2011 - UK GlaxoSmithKline (LON: GSK) and US XenoPort Inc (NASDAQ: XNPT) said yesterday that the US Food and Drug Administration (FDA) has approved Horizant (gabapentin enacarbil) Extended-Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome in adults.
Horizant is under review for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).